Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Alyaa A. Ramadan"'
Autor:
Nabila A. El-Sheridy, Riham M. El-Moslemany, Alyaa A. Ramadan, Maged W. Helmy, Labiba K. El-Khordagui
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 906-919 (2021)
Itraconazole (ITC), a well-tolerated antifungal drug, exerts multiple anticancer effects which justified its preclinical and clinical investigation as potential anti-cancer agent with reduced side effects. Enhancement of ITC anti-cancer efficacy woul
Externí odkaz:
https://doaj.org/article/3766e56650ec49d39e6083a1c362f660
Autor:
Lubna M. Eldesouky, Riham M. El-Moslemany, Alyaa A. Ramadan, Mahmoud H. Morsi, Nawal M. Khalafallah
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 360 (2021)
An ophthalmic cyclosporine (CsA) formulation based on Lipid nanocapsules (LNC) was developed for dry eye management, aiming to provide targeting to ocular tissues with long-term drug levels and maximum tolerability. CsA-LNC were of small particle siz
Externí odkaz:
https://doaj.org/article/512d643aa90a4b8e806eab77d327afe7
Autor:
Nabila A, El-Sheridy, Riham M, El-Moslemany, Alyaa A, Ramadan, Maged W, Helmy, Labiba K, El-Khordagui
Publikováno v:
Journal of Biomedical Nanotechnology. 18:97-111
Itraconazole (ITC), an antifungal drug with anticancer activity, shows potential for oral treatment of skin cancer. There is clinical need for topical ITC for treating low-risk skin carcinogenesis. Our objective was to develop ITC nanoformulations wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84269e90fe1db17bb9c7f030177a7599
https://doi.org/10.1166/jbn.2022.3217
https://doi.org/10.1166/jbn.2022.3217
Autor:
Hassan Nehme, Patrick Saulnier, Alyaa A Ramadan, Viviane Cassisa, Catherine Guillet, Matthieu Eveillard, Anita Umerska
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0189950 (2018)
Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity. Hence, the aims of this study w
Externí odkaz:
https://doaj.org/article/5559c656e06446aeb8d8e045cf270fc6
Autor:
Alyaa A. Ramadan, Maged W. Helmy, Nabila A. El-Sheridy, Labiba K. El-Khordagui, Riham M. El-Moslemany
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 906-919 (2021)
Itraconazole (ITC), a well-tolerated antifungal drug, exerts multiple anticancer effects which justified its preclinical and clinical investigation as potential anti-cancer agent with reduced side effects. Enhancement of ITC anti-cancer efficacy woul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ee542415955c1b8719cea0b3d2efbf
https://doi.org/10.1080/10717544.2021.1917728
https://doi.org/10.1080/10717544.2021.1917728
Publikováno v:
Journal of Materials Science: Materials in Electronics. 31:5599-5607
Herein through the study of structural, electrical, and magnetic properties of Ca-doped bismuth ferrite Bi1−xCaxFeO3-(x/2)+δ, Rietveld analysis of the X-ray diffraction patterns shows a tendency of structural phase transition from hexagonal into t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84bef817b9c8df915442330636539014
https://doi.org/10.1007/s10854-020-03126-y
https://doi.org/10.1007/s10854-020-03126-y
Publikováno v:
International Journal of Nanomedicine
Introduction Liver fibrosis represents a serious global disease with no approved treatment. Tanshinone IIA (TSIIA) is a phytomedicine with documented activity in treating many hepatic disorders. TSIIA has been reported to have potent anti-inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8bd24a5bd074a337a5277b3472ee055
https://www.dovepress.com/modified-lipid-nanocapsules-for-targeted-tanshinone-iia-delivery-in-li-peer-reviewed-fulltext-article-IJN
https://www.dovepress.com/modified-lipid-nanocapsules-for-targeted-tanshinone-iia-delivery-in-li-peer-reviewed-fulltext-article-IJN
Autor:
Maha M Eissa, Riham M El-Moslemany, Alyaa A Ramadan, Eglal I Amer, Mervat Z El-Azzouni, Labiba K El-Khordagui
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141788 (2015)
Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of breast cancer and oral therapy of visceral leishmaniasis. Recently, the drug was reported in in vitro and preclinical studies to exert significant act
Externí odkaz:
https://doaj.org/article/3e6ae825d2804eba8369c5d04c26fb48
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 181:623-631
There is a growing clinical demand for topical itraconazole (ITC) delivery systems because of the expanding potential of the drug for topical fungal and non-fungal applications. Lipid-based nanocarriers offer great promise in this respect. In the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e96c5b6a6c56022b9e07ca1fa07c17cd
https://doi.org/10.1016/j.colsurfb.2019.05.057
https://doi.org/10.1016/j.colsurfb.2019.05.057
Autor:
Nabila A, El-Sheridy, Riham M, El-Moslemany, Alyaa A, Ramadan, Maged W, Helmy, Labiba K, El-Khordagui
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Itraconazole (ITC), a well-tolerated antifungal drug, exerts multiple anticancer effects which justified its preclinical and clinical investigation as potential anti-cancer agent with reduced side effects. Enhancement of ITC anti-cancer efficacy woul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa295a6abb99a5bfd739e2897a9d6284
https://pubmed.ncbi.nlm.nih.gov/33960245
https://pubmed.ncbi.nlm.nih.gov/33960245